DiaMedica - About the company
DiaMedica is a public company based in Minneapolis (United States), founded in 2000. It operates as a Developing innovative therapies for vascular diseases like preeclampsia and acute ischemic stroke. DiaMedica has raised an undisclosed amount in funding.
Company Details
Developing innovative therapies for vascular diseases like preeclampsia and acute ischemic stroke. The company is focused on improving the lives of individuals battling serious vascular diseases by developing innovative therapies that reduce ischemia. With a focus on preeclampsia and acute ischemic stroke, they are dedicated to advancing patient care through a novel approach that centers around improving blood flow to ischemic tissue to improve patient outcomes. Their investigational drug candidate is intended to restore normal levels of a naturally occurring protein, which is intended to allow patients to naturally regulate their blood flow and maintain vascular homeostasis as well as reduce inflammation and oxidative stress. They are conducting clinical trials to explore the safety and effectiveness of their drug candidate. This research aims to address significant unmet medical needs in treating stroke patients and pregnancy complications.
- Website
- www.diamedica.com/
- Email ID
- *****@diamedica.com
- Registered Address
- Minneapolis, Minnesota
Key Metrics
Founded Year
2000
Location
Minneapolis, United States
Stage
Public
Latest Funding Round
Investors
Employee Count
46 as on May 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with DiaMedica
DiaMedica is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DIAMEDICA USA, INC. CIN: 331224644 , United States, Active | Dec 26, 999 | - | 27 (As on Dec 31, 2024) | - |
Diamedica CIN: 40003469042 , Latvia, Active | Nov 17, 1999 | €1M - €10M (As on Dec 31, 2024) | 28 (As on Dec 31, 2023) | - |
DIAMEDICA THERAPEUTICS INC. CIN: 1401040 , United States, Active | $0 - $1M (As on Dec 31, 2018) | - | - |
DiaMedica's IPO details
DiaMedica got listed on Jan 07, 2008.
Click here to take a look at DiaMedica's IPO in detail
Sign up to download DiaMedica's company profile
DiaMedica's funding and investors
DiaMedica has raised funding over 12 rounds. Its first funding round was on Mar 18, 2009. DiaMedica has 4 institutional investors.
Here is the list of recent funding rounds of DiaMedica:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 21, 2025 | 9963310 | Post IPO | 9082343 | 5724815 | 1866239 | 9274760 |
Jun 28, 2024 | 7004059 | Post IPO | 2726059 | 3709420 | 4046779 | 5178774 |
Jun 26, 2023 | 6642472 | Post IPO | 5682744 | 8517936 | 7410206 | 6860074 |
View details of DiaMedica's funding rounds and investors
DiaMedica's founders and board of directors
Founder? Claim ProfileDiaMedica's employee count trend
DiaMedica has 46 employees as of May 26. Here is DiaMedica's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
DiaMedica's Investments and acquisitions
DiaMedica has acquired SanoMune. DiaMedica has not made any investments as of now.Reports related to DiaMedica
Here is the latest report on DiaMedica's geography:
News related to DiaMedica
Media has covered DiaMedica for a total of 19 events in the last 1 year, 8 of them have been about company updates and 1 about people movement.
•
DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical ProgramBusiness Wire•Jun 16, 2026•DiaMedica
•
•
DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare ConferenceBusiness Wire•May 12, 2026•DiaMedica
•
•
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business HighlightsBusiness Wire•Mar 30, 2026•DiaMedica
•
Cooperman Leon G Raises Position in DiaMedica Therapeutics, Inc. $DMACMarketBeat•Mar 15, 2026•DiaMedica
•
•
•
DiaMedica Announces Formation of Development Advisory Group for Its Diabetes ProductsTechnology Networks•Jan 06, 2026•DiaMedica
•
Jan Stahlberg Acquires 73,099 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) StockMarketBeat•Dec 09, 2025•DiaMedica
Are you a Founder ?
FAQs about DiaMedica
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company